Soluble P-selectin: The next step

Thrombosis Research

Volumn 133, Issue 1, 2014, Pages 3-4

  Blann, Andrew D ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Platelets; soluble P selectin; thrombosis; VTE

Indexed keywords

ACETYLSALICYLIC ACID; ANTIVITAMIN K; CELL ADHESION MOLECULE; PADGEM PROTEIN; TROPONIN;

ACUTE CORONARY SYNDROME; ARTHRITIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; CORONARY CARE UNIT; DEEP VEIN THROMBOSIS; DEGRANULATION; EDITORIAL; ELECTROCARDIOGRAM; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; THORAX PAIN; THROMBOCYTE ACTIVATION; THROMBOCYTE VOLUME; THROMBOEMBOLISM; THROMBOSIS; VENOUS THROMBOEMBOLISM;

PLATELETS; SOLUBLE P SELECTIN; THROMBOSIS; VTE;

BLOOD PLATELETS; HUMANS; P-SELECTIN; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84890547106     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2013.10.030     Document Type: Editorial

References (44)

1. V. Fuster, L. Badimon, J.J. Badimon, and J.H. Chesebro The pathogenesis of coronary artery disease and the acute coronary syndromes N Engl J Med 326 1992 242 250
2. M. Gawaz Do platelets trigger atherosclerosis? Thromb Haemost 90 2003 971 972
3. S. Massberg, K. Brand, S. Gruner, S. Page, E. Müller, and I. Müller A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation J Exp Med 196 2002 887 896
4. A. Strano, G. Davi, and C. Patrono In vivo platelet activation in diabetes mellitus Semin Thromb Hemost 17 1991 422 425
5. E. Bastida, and A. Ordinas Platelet contribution to the formation of metastatic foci: the role of cancer cell induced platelet activation Haemostasis 18 1988 29 36
6. G.J. Del Zoppo The role of platelets in ischaemic stroke Neurology 3 Suppl. 3 1998 S9 S14
7. Pulmonary Embolism Prevention (PEP) Trial Collaborative Group Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin Lancet 355 2000 1295 1302
8. ISIS-2 Collaborative Group Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 Lancet ii 1988 350 360
9. E. Thaulow, J. Erikssen, L. Sandvik, H. Stormorken, and P.F. Cohn Blood platelet count and function are related to total and cardiovascular death in apparently healthy men Circulation 84 1991 613 617
10. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients Br Med J 324 2002 71 86
11. K.L. Kaplan, and J. Owen Plasma levels of beta-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo Blood 57 1981 199 202
12. J. Fareed, D.A. Hoppensteadt, F. Leya, O. Iqbal, H. Wolf, and R. Bick Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes Clin Chem 44 1998 1845 1853
13. P. Ferroni, S. Riondino, N. Vazzana, N. Santoro, F. Guadagni, and G. Davì Biomarkers of platelet activation in acute coronary syndromes Thromb Haemost 108 2012 1109 1123
14. D. Gurney, G.Y.H. Lip, and A.D. Blann A reliable marker of platelet activation: Does it exist? Am J Hematol 70 2002 139 144
15. P.E. Stenberg, R.P. McEver, M.A. Shuman, Y.V. Jacques, and D.F. Bainton A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation J Cell Biol 101 1985 880 886
16. A. Celi, B. Furie, and B.C. Furie PADGEM: an adhesion receptor for leukocytes on stimulated platelets and endothelial cells Proc Soc Exp Biol Med 198 1991 703 709
17. L.C. Dunlop, M.P. Skinner, L.J. Bendall, E.J. Favaloro, P.A. Castaldi, and J.J. Gorman Characterization of GMP-140 (P-selectin) as a circulating plasma protein J Exp Med 175 1992 1147 1150
18. M. Katayama, M. Handa, Y. Araki, H. Ambo, Y. Kawai, and K. Watanabe Soluble P-selectin is present in normal circulation and its plasma level is elevated in patients with thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome Br J Haematol 84 1993 702 710
19. A.D. Blann, M. Dobrotova, P. Kubisz, and C.N. von McCollum Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis Thromb Haemost 74 1995 626 630
20. B. Jilma, P. Fasching, C. Ruthner, A. Rumplmayr, S. Ruzicka, and S. Kapiotis Elevated circulating P-selectin in insulin dependent diabetes mellitus Thromb Haemost 76 1996 328 332
21. A.D. Michelson, M.R. Barnard, H.B. Hechtman, H. MacGregor, R.J. Connolly, and J. Loscalzo In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function Proc Natl Acad Sci U S A 93 1996 11877 11882
22. A.D. Blann, and G.Y. Lip Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis 128 1997 135 138
23. S. Tsiara, M. Elisaf, I.A. Jagroop, and D.P. Mikhailidis Platelets as predictors of vascular risk: is there a practical index of platelet activity? Clin Appl Thromb Hemost 9 2003 177 190
24. J. Kappelmayer, B. Nagy Jr., K. Miszti-Blasius, Z. Hevessy, and H. Setiadi The emerging value of P-selectin as a disease marker Clin Chem Lab Med 42 2004 475 486
25. I. Pabinger, and C. Ay Biomarkers and venous thromboembolism Arterioscler Thromb Vasc Biol 29 2009 332 336
26. P. André, D. Hartwell, I. Hrachovinová, S. Saffaripour, and D.D. Wagner Pro-coagulant state resulting from high levels of soluble P-selectin in blood Proc Natl Acad Sci U S A 97 2000 13835 13840
27. D.D. Myers Jr., R. Schaub, S.K. Wrobleski, F.J. Londy III, B.A. Fex, and A.M. Chapman P-selectin antagonism causes dose-dependent venous thrombosis inhibition Thromb Haemost 85 2001 423 429
28. D.D. Myers Jr., S.K. Wrobleski, C. Longo, P.W. Bedard, N. Kaila, and G.D. Shaw Resolution of venous thrombosis using a novel oral small-molecule inhibitor of P-selectin (PSI-697) without anticoagulation Thromb Haemost 97 2007 400 407
29. D.D. Myers Jr., J.E. Rectenwald, P.W. Bedard, N. Kaila, G.D. Shaw, and R.G. Schaub Decreased venous thrombosis with an oral inhibitor of P selectin J Vasc Surg 42 2005 329 336
30. R. Body, P. Pemberton, F. Ali, G. McDowell, S. Carley, and A. Smith Low soluble P-selectin may facilitate early exclusion of acute myocardial infarction Clin Chim Acta 412 2011 614 618
31. P. Zamani, G.G. Schwartz, A.G. Olsson, N. Rifai, W. Bao, and P. Libby Inflammatory biomarkers, death, and recurrent nonfatal coronary events after an acute coronary syndrome in the MIRACL study J Am Heart Assoc 2 1 Jan 28 2013 e003103 10.1161/JAHA.112.003103 [PMID: 23525424]
32. A. Smith, J.W. Quarmby, M. Collins, S.M. Lockhart, and K.G. Burnand Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis Thromb Haemost 82 1999 1593 1599
33. A.D. Blann, W.M.P. Noteboom, and F.R. Rosendaal Increased levels of soluble P-selectin following vein thrombosis: cause or effect? Br J Haematol 108 2000 191 193
34. M. Bozic, A. Blinc, and M. Stegnar D-dimer, other markers of haemostasis activation and soluble adhesion molecules in patients with different clinical probabilities of deep vein thrombosis Thromb Res 108 2002 107 114
35. J.E. Rectenwald, D.D. Myers Jr., A.E. Hawley, C. Longo, P.K. Henke, and K.E. Guire D-dimer, P-selectin, and microparticles: novel markers to predict deep venous thrombosis. A pilot study Thromb Haemost 94 2005 1312 1317
36. C. Ay, L.V. Jungbauer, T. Sailer, T. Tengler, S. Koder, and A. Kaider High concentrations of soluble P-selectin are associated with risk of venous thromboembolism and the P-selectin Thr715 variant Clin Chem 53 2007 1235 1243
37. P. Bugert, I. Pabinger, K. Stamer, R. Vormittag, R.C. Skeate, and M.M. Wahi The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154 Thromb Haemost 97 2007 573 580
38. T. Gremmel, C. Ay, D. Seidinger, I. Pabinger, S. Panzer, and R. Koppensteiner Soluble p-selectin, D-dimer, and high-sensitivity C-reactive protein after acute deep vein thrombosis of the lower limb J Vasc Surg 54 2011 48S 55S
39. E. Ramacciotti, S. Blackburn, A.E. Hawley, F. Vandy, N. Ballard-Lipka, and C. Stabler Evaluation of soluble P-selectin as a marker for the diagnosis of deep venous thrombosis Clin Appl Thromb Hemost 17 2011 425 431
40. C. Ay, R. Simanek, R. Vormittag, D. Dunkler, G. Alguel, and S. Koder High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the Vienna Cancer and Thrombosis Study (CATS) Blood 112 2008 2703 2708
41. P.A. Kyrle, G. Hron, S. Eichinger, and O. Wagner Circulating P-selectin and the risk of recurrent venous thromboembolism Thromb Haemost 97 2007 880 883
42. C.N. Antonopoulos, G.S. Sfyroeras, J.D. Kakisis, K.G. Moulakakis, and C.D. Liapis The role of soluble P selectin in the diagnosis of venous thromboembolism Thromb Res Aug 23 2013 10.1016/j.thromres.2013.08.014
43. F.C. Vandy, C. Stabler, A.M. Eliassen, A.E. Hawley, K.E. Guire, and D.D. Myers Soluble P-selectin for the diagnosis of lower extremity deep venous thrombosis J Vasc Surg Venous Lymphat Disord 1 2013 117 125
44. J. Kelly, A. Rudd, R.R. Lewis, and B.J. Hunt Plasma D-dimers in the diagnosis of venous thromboembolism Arch Intern Med 162 2002 747 756